Ginkgo Bioworks Holdings Class A financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

깅코 바이오웍스 홀딩스NYSE:DNA · New York Stock Exchange · Healthcare

$14.98+21.30%

2026-10-05 close · prelim

Ginkgo Bioworks Holdings Class A's published financial data is dated 2026-10-04. 2024 revenue was $227M. 2024 operating profit was −$588M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy